Yunfei Zhang, Jing Wu, Abudusalamu Tuersunmaimaiti, Gang Yao, Xiapukaiti Fulati, Yilizhati Azhati, Alimujiang Mamuti, Tao Li, Tuerhongjiang Tuxun
{"title":"预测腹膜后原发性恶性和良性肿瘤患者临床预后的预后图。","authors":"Yunfei Zhang, Jing Wu, Abudusalamu Tuersunmaimaiti, Gang Yao, Xiapukaiti Fulati, Yilizhati Azhati, Alimujiang Mamuti, Tao Li, Tuerhongjiang Tuxun","doi":"10.1007/s12672-025-03730-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary retroperitoneal tumor (PRT) is a relatively rare tumor with diverse histological and molecular types. We aim to develop and validate a concise prognostic nomogram for patients with benign and malignant PRT.</p><p><strong>Methods: </strong>The clinical data of 206 PRT patients who underwent surgical management in authors' institution during January 2016 and December 2021 were analyzed. Logistic regression was used to select independent risk variables of binary outcome, while COX regression was performed for time-to-event. A predictive nomogram was developed based on multivariate analyses.</p><p><strong>Results: </strong>Of the reported 206 PRTs, 113 patients were benign (54.85%) and 93 (45.15%) were malignant. Radical resection, extended radical resection and cytoreductive resection were performed in 141, 50 and 15 patients, respectively. The comprehensive complication index (CCI) was higher than 26.2% in 14 cases. Postoperative recurrence was experienced in 20 (9.7%) cases during the median 49 months. Nomogram was developed to predict severe complication and parameters included time of surgery, loss of blood and type of surgery with a moderate prediction capability [Area under curve (AUC) = 0.64)] after interval validation. While model for postoperative recurrence prediction includes parameters as chemotherapy, metastasis, combined resection and time of surgery with acceptable performance (AUC = 0.913). Overall survival is related to tumor size, metastasis and pathology as risk factors and the prediction capability was good (AUC = 0.800).</p><p><strong>Conclusion: </strong>The proposed nomogram showed favorable predictive accuracy for prognosis in patients with PRTs. This has the potential to contribute to clinical decision-making.</p>","PeriodicalId":11148,"journal":{"name":"Discover. Oncology","volume":"16 1","pages":"1892"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12528585/pdf/","citationCount":"0","resultStr":"{\"title\":\"A prognostic nomogram to predict clinical outcomes of patients with primary malignant and benign retroperitoneal tumors.\",\"authors\":\"Yunfei Zhang, Jing Wu, Abudusalamu Tuersunmaimaiti, Gang Yao, Xiapukaiti Fulati, Yilizhati Azhati, Alimujiang Mamuti, Tao Li, Tuerhongjiang Tuxun\",\"doi\":\"10.1007/s12672-025-03730-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Primary retroperitoneal tumor (PRT) is a relatively rare tumor with diverse histological and molecular types. We aim to develop and validate a concise prognostic nomogram for patients with benign and malignant PRT.</p><p><strong>Methods: </strong>The clinical data of 206 PRT patients who underwent surgical management in authors' institution during January 2016 and December 2021 were analyzed. Logistic regression was used to select independent risk variables of binary outcome, while COX regression was performed for time-to-event. A predictive nomogram was developed based on multivariate analyses.</p><p><strong>Results: </strong>Of the reported 206 PRTs, 113 patients were benign (54.85%) and 93 (45.15%) were malignant. Radical resection, extended radical resection and cytoreductive resection were performed in 141, 50 and 15 patients, respectively. The comprehensive complication index (CCI) was higher than 26.2% in 14 cases. Postoperative recurrence was experienced in 20 (9.7%) cases during the median 49 months. Nomogram was developed to predict severe complication and parameters included time of surgery, loss of blood and type of surgery with a moderate prediction capability [Area under curve (AUC) = 0.64)] after interval validation. While model for postoperative recurrence prediction includes parameters as chemotherapy, metastasis, combined resection and time of surgery with acceptable performance (AUC = 0.913). Overall survival is related to tumor size, metastasis and pathology as risk factors and the prediction capability was good (AUC = 0.800).</p><p><strong>Conclusion: </strong>The proposed nomogram showed favorable predictive accuracy for prognosis in patients with PRTs. This has the potential to contribute to clinical decision-making.</p>\",\"PeriodicalId\":11148,\"journal\":{\"name\":\"Discover. Oncology\",\"volume\":\"16 1\",\"pages\":\"1892\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-10-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12528585/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Discover. Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12672-025-03730-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discover. Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-025-03730-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:原发性腹膜后肿瘤(PRT)是一种相对罕见的肿瘤,具有多种组织学和分子类型。我们的目标是开发和验证一个简明的预后图,为患者的良性和恶性PRT。方法:分析2016年1月至2021年12月笔者所在单位206例PRT手术患者的临床资料。二元结局的独立风险变量选择采用Logistic回归,时间-事件回归采用COX回归。在多变量分析的基础上,建立了预测模态图。结果:206例prt中,良性113例(54.85%),恶性93例(45.15%)。分别行根治性切除141例,扩大根治性切除50例,细胞减原性切除15例。14例患者综合并发症指数(CCI)高于26.2%。术后49个月内有20例(9.7%)复发。采用Nomogram预测严重并发症,参数包括手术时间、出血量、手术类型等,经区间验证,预测能力中等[曲线下面积(Area under curve, AUC) = 0.64]。术后复发预测模型包括化疗、转移、联合切除、手术时间等参数(AUC = 0.913)。总生存率与肿瘤大小、转移及病理相关,预测能力较好(AUC = 0.800)。结论:所提出的nomogram对prt患者的预后具有较好的预测准确性。这有可能有助于临床决策。
A prognostic nomogram to predict clinical outcomes of patients with primary malignant and benign retroperitoneal tumors.
Background: Primary retroperitoneal tumor (PRT) is a relatively rare tumor with diverse histological and molecular types. We aim to develop and validate a concise prognostic nomogram for patients with benign and malignant PRT.
Methods: The clinical data of 206 PRT patients who underwent surgical management in authors' institution during January 2016 and December 2021 were analyzed. Logistic regression was used to select independent risk variables of binary outcome, while COX regression was performed for time-to-event. A predictive nomogram was developed based on multivariate analyses.
Results: Of the reported 206 PRTs, 113 patients were benign (54.85%) and 93 (45.15%) were malignant. Radical resection, extended radical resection and cytoreductive resection were performed in 141, 50 and 15 patients, respectively. The comprehensive complication index (CCI) was higher than 26.2% in 14 cases. Postoperative recurrence was experienced in 20 (9.7%) cases during the median 49 months. Nomogram was developed to predict severe complication and parameters included time of surgery, loss of blood and type of surgery with a moderate prediction capability [Area under curve (AUC) = 0.64)] after interval validation. While model for postoperative recurrence prediction includes parameters as chemotherapy, metastasis, combined resection and time of surgery with acceptable performance (AUC = 0.913). Overall survival is related to tumor size, metastasis and pathology as risk factors and the prediction capability was good (AUC = 0.800).
Conclusion: The proposed nomogram showed favorable predictive accuracy for prognosis in patients with PRTs. This has the potential to contribute to clinical decision-making.